BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 21817854)

  • 1. Transcutaneous and intradermal vaccination.
    Combadiere B; Liard C
    Hum Vaccin; 2011 Aug; 7(8):811-27. PubMed ID: 21817854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice.
    Nicolas JF; Guy B
    Expert Rev Vaccines; 2008 Oct; 7(8):1201-14. PubMed ID: 18844594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Particle-based vaccines for transcutaneous vaccination.
    Combadière B; Mahé B
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):293-315. PubMed ID: 17915323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tailored immunity by skin antigen-presenting cells.
    Levin C; Perrin H; Combadiere B
    Hum Vaccin Immunother; 2015; 11(1):27-36. PubMed ID: 25483512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with DNA through the skin.
    Peachman KK; Rao M; Alving CR
    Methods; 2003 Nov; 31(3):232-42. PubMed ID: 14511956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in transcutaneous vaccine delivery: do all ways lead to Rome?
    Bal SM; Ding Z; van Riet E; Jiskoot W; Bouwstra JA
    J Control Release; 2010 Dec; 148(3):266-82. PubMed ID: 20869998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dendritic cells of mucosa and skin: "recruited for vaccination"].
    Le Borgne M; Dubois B; Kaiserlian D
    Med Sci (Paris); 2007 Oct; 23(10):819-25. PubMed ID: 17937889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insight into the immunobiology of human skin and functional specialization of skin dendritic cell subsets to innovate intradermal vaccination design.
    Teunissen MB; Haniffa M; Collin MP
    Curr Top Microbiol Immunol; 2012; 351():25-76. PubMed ID: 21833835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the murine cutaneous dendritic cell network to improve intradermal vaccination strategies.
    Ginhoux F; Ng LG; Merad M
    Curr Top Microbiol Immunol; 2012; 351():1-24. PubMed ID: 21058006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of epidermal Langerhans cells with antigenic proteins: attempts to harness their properties for immunotherapy.
    Flacher V; Sparber F; Tripp CH; Romani N; Stoitzner P
    Cancer Immunol Immunother; 2009 Jul; 58(7):1137-47. PubMed ID: 18677477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting skin dendritic cells to improve intradermal vaccination.
    Romani N; Flacher V; Tripp CH; Sparber F; Ebner S; Stoitzner P
    Curr Top Microbiol Immunol; 2012; 351():113-38. PubMed ID: 21253784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent insights into cutaneous immunization: How to vaccinate via the skin.
    Engelke L; Winter G; Hook S; Engert J
    Vaccine; 2015 Sep; 33(37):4663-74. PubMed ID: 26006087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Skin vaccination].
    Naito S
    Nihon Rinsho; 2008 Oct; 66(10):1888-93. PubMed ID: 18939486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intradermal immunization triggers epidermal Langerhans cell mobilization required for CD8 T-cell immune responses.
    Liard C; Munier S; Joulin-Giet A; Bonduelle O; Hadam S; Duffy D; Vogt A; Verrier B; Combadière B
    J Invest Dermatol; 2012 Mar; 132(3 Pt 1):615-25. PubMed ID: 22170490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routing dependent immune responses after experimental R848-adjuvated vaccination.
    van Aalst S; Jansen MAA; Ludwig IS; van der Zee R; van Eden W; Broere F
    Vaccine; 2018 Mar; 36(11):1405-1413. PubMed ID: 29409680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intradermal granulocyte-macrophage colony-stimulating factor alters cutaneous antigen-presenting cells and differentially affects local versus distant immunization in humans.
    Kremer IB; Stevens SR; Gould JW; DiCarlo J; Quinby GE; Cooper KD
    Clin Immunol; 2000 Jul; 96(1):29-37. PubMed ID: 10873425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and validation of a skin model for the evaluation of intradermal powder injection devices.
    Deng Y; Winter G; Myschik J
    Eur J Pharm Biopharm; 2012 Jun; 81(2):360-8. PubMed ID: 22484250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of a transcutaneous vaccination system using a hydrogel patch].
    Ishii Y; Okada N; Nakagawa S
    Nihon Rinsho; 2008 Oct; 66(10):1848-50. PubMed ID: 18939480
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeting of HIV-p24 particle-based vaccine into differential skin layers induces distinct arms of the immune responses.
    Liard C; Munier S; Arias M; Joulin-Giet A; Bonduelle O; Duffy D; Shattock RJ; Verrier B; Combadière B
    Vaccine; 2011 Aug; 29(37):6379-91. PubMed ID: 21554912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcutaneous immunization and immunostimulant strategies: capitalizing on the immunocompetence of the skin.
    Glenn GM; Kenney RT; Ellingsworth LR; Frech SA; Hammond SA; Zoeteweij JP
    Expert Rev Vaccines; 2003 Apr; 2(2):253-67. PubMed ID: 12899576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.